angiotensin ii has been researched along with Electron Transport Chain Deficiencies, Mitochondrial in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cui, Y; Gao, P; Li, L; Li, Y; Lin, S; Liu, D; Lu, Z; Wang, B; Wei, X; Xiong, S; Zhang, H; Zhao, Z; Zhu, Z | 1 |
Heron, RJ | 1 |
Bian, Z; Chen, X; Gu, C; Li, S; Lu, Y; Wu, H; Xu, J; Yang, D | 1 |
Baumann, M; Eriksson, O; Finckenberg, P; Haasio, K; Kytö, V; Lalowski, MM; Levijoki, J; Luft, FC; Merasto, S; Mervaala, E; Muller, DN; Oresic, M | 1 |
de Cavanagh, EM; Ferder, L; Ferder, M; Inserra, F | 1 |
Dikalov, SI; Doughan, AK; Harrison, DG | 1 |
1 review(s) available for angiotensin ii and Electron Transport Chain Deficiencies, Mitochondrial
Article | Year |
---|---|
From mitochondria to disease: role of the renin-angiotensin system.
Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Diabetes Mellitus; Humans; Hypertension; Mitochondria; Mitochondrial Diseases; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System | 2007 |
5 other study(ies) available for angiotensin ii and Electron Transport Chain Deficiencies, Mitochondrial
Article | Year |
---|---|
Activation of Transient Receptor Potential Melastatin Subtype 8 Attenuates Cold-Induced Hypertension Through Ameliorating Vascular Mitochondrial Dysfunction.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Calcium; Cell Respiration; Cells, Cultured; Cold Temperature; Dietary Supplements; Homeostasis; Hypertension; Male; Menthol; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Muscle; Mitochondrial Diseases; Muscle, Smooth, Vascular; Reactive Oxygen Species; rho-Associated Kinases; TRPM Cation Channels; Vasoconstriction | 2017 |
Response to "The unknown: respiratory effects of cleaning up an oil spill".
Topics: Angiotensin II; Animals; Endothelial Cells; Mitochondrial Diseases; Oxidative Stress; Vascular Diseases; Vasoconstrictor Agents | 2013 |
Beneficial effects of astragaloside IV against angiotensin II-induced mitochondrial dysfunction in rat vascular smooth muscle cells.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Antioxidants; Cells, Cultured; DNA, Mitochondrial; Male; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Diseases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Saponins; Signal Transduction; Transcription Factors; Triterpenes | 2015 |
Caloric restriction ameliorates angiotensin II-induced mitochondrial remodeling and cardiac hypertrophy.
Topics: Angiotensin II; Angiotensinogen; Animals; Apoptosis; Autophagy; Blood Pressure; Body Temperature; Caloric Restriction; Cardiomegaly; Endoplasmic Reticulum Stress; Energy Metabolism; Heart Rate; Humans; Mitochondria; Mitochondrial Diseases; Myocytes, Cardiac; Oxidative Stress; Proteome; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Survival Rate; Vasoconstrictor Agents | 2012 |
Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction.
Topics: Angiotensin II; Animals; Aorta; Cattle; Cell Respiration; Cells, Cultured; Endothelial Cells; Glutathione; Hydrogen Peroxide; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Diseases; Nitric Oxide; Oxidative Stress; Superoxides; Vascular Diseases; Vasoconstrictor Agents | 2008 |